Publications by authors named "Geoffrey R Weiss"

Claim this Profile
S
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
Howard A Burris, Jeffrey R Infante, Stephen M Ansell, John J Nemunaitis, Geoffrey R Weiss

J Clin Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma NOS1 expression promotes dysfunctional IFN signaling.
Qiuzhen Liu, Sara Tomei, Maria Libera Ascierto, Valeria De Giorgi, Davide Bedognetti, Geoffrey R Weiss

J Clin Invest· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Craig L Slingluff, Gina R Petroni, Kerrington R Molhoek, David L Brautigan, Kimberly A Chianese-Bullock, Geoffrey R Weiss

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer.
Patricia J Hollen, Richard J Gralla, Randy A Jones, Christopher Y Thomas, David R Brenin, Geoffrey R Weiss

Support Care Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical management of the patient with metastatic melanoma to the heart.
Joshua M Judge, John D Tillou, Craig L Slingluff, John A Kern, Irving L Kron, Geoffrey R Weiss

J Card Surg· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report.
Robert C Schutt, Trish A Gordon, Ruchi Bhabhra, Helen P Cathro, Stephen L Cook, Geoffrey R Weiss

J Med Case Rep· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
Geoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, Yingdong Zhao, Hui Liu

Clin Cancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Jayme B Stokes, Norris J Nolan, Edward B Stelow, Dustin M Walters, Geoffrey R Weiss

Ann Surg Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.
Joseph M Baisden, Michel Kahaleh, Geoffrey R Weiss, Hilary Sanfey, Christopher A Moskaluk

Gastrointest Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Michel Kahaleh, Rajnish Mishra, Vanessa M Shami, Patrick G Northup, Carl L Berg, Geoffrey R Weiss

Clin Gastroenterol Hepatol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Monica M Mita, Eric K Rowinsky, Leonardo Forero, S Gail Eckhart, Elzbieta Izbicka, Geoffrey R Weiss

Cancer Chemother Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Angela M Davies, Kari Chansky, Derick H M Lau, Bryan R Leigh, Laurie E Gaspar, Geoffrey R Weiss

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
Paul J Hesketh, Jason McCoy, Frank R Dunphy, James D Bearden, Geoffrey R Weiss

J Thorac Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group Study 9024.
Gregory P Swanson, James Faulkner, Stephen R Smalley, Mark J Noble, Ronald L Stephens, Geoffrey R Weiss

J Urol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study.
Michael F Sarosdy, Catherine M Tangen, Geoffrey R Weiss, Blake R Nestok, Mitchell C Benson

Urol Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Elizabeth A Poplin, Jacqueline K Benedetti, Norman C Estes, Daniel G Haller, Robert J Mayer, Geoffrey R Weiss

J Clin Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.
Mace L Rothenberg, P Y Liu, Sharon Wilczynski, William A Nahhas, Gaye L Winakur, Geoffrey R Weiss

Gynecol Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current issues in the management of advanced squamous cell carcinoma of the penis.
Samira Syed, Tony Y Eng, Charles R Thomas, Ian M Thompson, Geoffrey R Weiss

Urol Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
Martin J Edelman, Joseph I Clark, Kari Chansky, Kathy Albain, Nirmala Bhoopalam, Geoffrey R Weiss

Clin Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms.
Lisa A Hammond, John R Eckardt, John G Kuhn, Stanton L Gerson, Tom Johnson, Geoffrey R Weiss

Clin Cancer Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder.
Geoffrey R Weiss, Michael A O'Donnell, Kevin Loughlin, Kristilyn Zonno, Robert J Laliberte

J Immunother· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
Martin J Edelman, Kari Chansky, Laurie E Gaspar, Bryan Leigh, Geoffrey R Weiss

J Clin Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.
Joseph I Clark, Michael B Atkins, Walter J Urba, Steven Creech, Robert A Figlin, Geoffrey R Weiss

J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial.
Maurie Markman, Tracy Glass, Harriet O Smith, Kenneth D Hatch, Geoffrey R Weiss

Gynecol Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of locally advanced bladder cancer: early vs deferred chemotherapy.
Samira Syed, Geoffrey R Weiss

World J Urol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis